Prefilled Syringes Market

Market Overview:

The global prefilled syringes market size reached USD 8.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. At present, Europe holds the largest market share across the globe due to the increasing demand for biologics, a growing preference for convenient and safe self-administration, and stringent regulatory standards promoting the adoption of advanced, contamination-free drug delivery systems.

A prefilled syringe is a single-dose packet of injectable vaccines that is disposable in nature. The usage of prefilled syringes significantly lowers the chances of drug contamination as it avoids the potential admixture-related contamination risks when syringes are inserted into a drug vial to draw out a dose. Combining this with a pre-sterilized syringe further increases safety, enables the easy and quick delivery of drugs in the case of emergencies, and eliminates the additional on-site vial cleaning and de-pyrogenation processes. Consequently, they are a preferred option to administer the drugs via the parenteral route for delivering a wide range of injectables, such as biosimilar and biologics.

Prefilled Syringes Market Trends:

Rising Demand for Injectable Drugs

The global demand for injectable drugs, especially biologics, vaccines, and therapeutic agents, represents one of the major factors driving the prefilled syringes market growth. Injectable medications are often preferred for their fast-acting effects, crucial for chronic diseases, cancers, and autoimmune conditions, which require precise, controlled dosages. In line with this, prefilled syringes offer a convenient, ready-to-use solution that reduces the risks of dosage errors, contamination, and preparation time. Furthermore, the rising prevalence of chronic diseases and increased focus on patient-centric healthcare drive the adoption of injectable drug formats, pushing pharmaceutical companies to increasingly use prefilled syringes for efficiency and safety.

Increasing Preference for Safety and Convenience

Patient safety and convenience are major factors influencing the growth of the market. Healthcare providers and patients prefer prefilled syringes due to their enhanced safety features, including reduced contamination risks and accurate dosing. This format reduces the risk of needlestick injuries, cross-contamination, and other hazards associated with traditional vials and syringes. In addition to this, with a growing emphasis on home healthcare and self-administration, prefilled syringes are becoming increasingly popular among patients, as they simplify the process, supporting ease of use and minimizing potential health risks. This, in turn, is contributing to the market growth significantly.

Advancements in Prefilled Syringe Technology

Significant technological advancements are expected to increase the overall prefilled syringes market share across the globe. Innovations in materials, like the use of glass alternatives and ultra-thin needles, improve syringe durability and patient comfort. The development of safety-engineered devices and auto-disable syringes further ensures accurate dosing and prevents accidental misuse. Moreover, advancements in prefilled syringe manufacturing, such as automated filling and sealing processes, enhance product quality and scalability. These technological improvements are essential as the pharmaceutical industry shifts toward complex biologics that require specialized, sterile packaging, making advanced prefilled syringes the preferred choice for numerous therapeutic applications.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global prefilled syringes market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on design, material, closing system, application, and end user.

Breakup by Design:

• Single-chamber Prefilled Syringes
• Dual-chamber Prefilled Syringes
• Customized Prefilled Syringes
   

Breakup by Material:

• Glass Prefilled Syringes
• Plastic Prefilled Syringes
   

Breakup by Closing System:

• Staked Needle System
• Luer Cone System
• Luer Lock Form System
   

Breakup by Application:

• Diabetes
• Anaphylaxis
• Rheumatoid Arthritis
• Oncology
• Others
   

Breakup by End User:

• Hospitals
• Clinics
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global prefilled syringes market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

• Abbott Laboratories
• B. Braun Melsungen AG
• Baxter International Inc.
• Bayer AG
• Becton Dickinson and Company
• Cardinal Health Inc.
• Catalent Inc.
• Fresenius SE & Co. KGaA
• Gerresheimer AG
• Nipro Corporation
• Schott AG
• Terumo Corporation
• West Pharmaceutical Services Inc.
   

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Prefilled Syringes Market News:

• In September 2024, BD, a leading global medical technology company, announced the commercial release of the BD Neopak XtraFlow™ Glass Prefillable Syringe and the latest capacity expansion of the BD Neopak™ Glass Prefillable Syringe platform to serve the growing market for biologic therapies.
• In April 2024, Laboratorios Farmacéuticos Rovi, S.A., a pan-European pharmaceutical company that specializes and engages in the research, development, contract manufacturing, and licensing of small molecules and biological medicines, announced that its subsidiary ROVI Pharma Industrial Services, S.A.U. agreed to support the manufacture of pre-filled syringes for a global pharmaceutical company.

Report Scope: